VivoSim Labs, Inc. Interest Expense
VivoSim Labs, Inc. (VIVS) reported Interest Expense of $0 for the 12-month period ending 2017-03-31, per its 10-K filed 2017-06-07.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2017-06-07
- VivoSim Labs, Inc. interest expense for the quarter ending 2015-06-30 was $3.00K.
- VivoSim Labs, Inc. interest expense for the quarter ending 2014-06-30 was $0.00, a 100.00% decline year-over-year.
- VivoSim Labs, Inc. interest expense for the quarter ending 2014-03-31 was $13.00K, a 80.00% decline year-over-year.
- VivoSim Labs, Inc. interest expense for the quarter ending 2013-12-31 was $0.00, a 100.00% decline year-over-year.
- VivoSim Labs, Inc. interest expense for fiscal 2017 was $0.00.
- VivoSim Labs, Inc. interest expense for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- VivoSim Labs, Inc. interest expense for fiscal 2015 was $1.00K, a 92.31% decline from fiscal 2014.
- VivoSim Labs, Inc. interest expense for fiscal 2014 was $13.00K.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month | Interest Expense 59 month | Interest Expense 62 month | Interest Expense 65 month | Interest Expense 68 month | Interest Expense 71 month | Interest Expense 74 month | Interest Expense 77 month | Interest Expense 80 month | Interest Expense 83 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-03-31 | $0.00 10-K · filed 2017-06-07 | |||||||||||||
| 2016-03-31 | $0.00 10-K · filed 2017-06-07 | |||||||||||||
| 2015-06-30 | $3.00K 10-Q · filed 2015-08-10 | |||||||||||||
| 2015-03-31 | $1.00K 10-K · filed 2017-06-07 | |||||||||||||
| 2014-06-30 | $0.00 10-Q · filed 2015-08-10 | $13.00K derived: sum of 2 quarters · filed 2015-08-10 | $13.00K derived: sum of 3 quarters · filed 2015-08-10 | $13.00K derived: sum of 4 quarters · filed 2015-08-10 | ||||||||||
| 2014-03-31 | $13.00K 10-K · filed 2014-06-10 | $13.00K derived: sum of 2 quarters · filed 2015-02-06 | $13.00K derived: sum of 3 quarters · filed 2015-02-06 | $13.00K 10-K · filed 2016-06-09 | $3.48M 10-K · filed 2014-06-10 | |||||||||
| 2013-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-06 | $0.00 derived: sum of 2 quarters · filed 2015-02-06 | $13.00K 10-Q · filed 2015-02-06 | $78.00K derived: sum of 4 quarters · filed 2015-06-09 | $3.48M 10-Q · filed 2014-02-06 | |||||||||
| 2013-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-07 | $13.00K 10-Q · filed 2014-11-07 | $78.00K derived: sum of 3 quarters · filed 2015-06-09 | $78.34K derived: sum of 4 quarters · filed 2015-06-09 | $3.48M 10-Q · filed 2013-11-08 | |||||||||
| 2013-06-30 | $13.00K 10-Q · filed 2014-08-08 | $78.00K derived: sum of 2 quarters · filed 2015-06-09 | $78.34K derived: sum of 3 quarters · filed 2015-06-09 | $78.55K derived: sum of 4 quarters · filed 2015-06-09 | $3.48M 10-Q · filed 2013-08-09 | |||||||||
| 2013-03-31 | $65.00K 10-K · filed 2015-06-09 | $65.34K derived: sum of 2 quarters · filed 2015-06-09 | $65.55K derived: sum of 3 quarters · filed 2015-06-09 | $65.00K derived: sum of 4 quarters · filed 2015-06-09 | $3.47M 10-KT · filed 2013-05-24 | |||||||||
| 2012-12-31 | $344.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-09 | $547.00 derived: sum of 2 quarters · filed 2015-06-09 | $0.00 derived: sum of 3 quarters · filed 2015-06-09 | $1.09M 10-K · filed 2015-06-09 | $3.41M 10-K · filed 2013-03-15 | |||||||||
| 2012-09-30 | $203.00 10-Q · filed 2012-11-14 | -$344.00 derived: sum of 2 quarters · filed 2012-11-14 | $1.09M 10-Q · filed 2012-11-14 | $2.86M derived: sum of 4 quarters · filed 2015-06-09 | $3.41M 10-Q · filed 2012-11-14 | |||||||||
| 2012-06-30 | -$547.00 derived: 10-Q 6 month − 10-K 3 month · filed 2012-08-14 | $1.09M 10-Q · filed 2012-08-14 | $2.86M derived: sum of 3 quarters · filed 2015-06-09 | $3.04M derived: sum of 4 quarters · filed 2015-06-09 | $3.41M 10-Q · filed 2012-08-14 | |||||||||
| 2012-03-31 | $1.09M 10-K · filed 2015-06-09 | $1.09M 10-Q · filed 2012-05-15 | $2.86M derived: sum of 2 quarters · filed 2015-06-09 | $3.04M derived: sum of 3 quarters · filed 2015-06-09 | $3.10M derived: sum of 4 quarters · filed 2015-06-09 | $3.41M 10-Q · filed 2012-05-15 | ||||||||
| 2011-12-31 | $1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-10 | $1.96M derived: sum of 2 quarters · filed 2014-06-10 | $2.01M derived: sum of 3 quarters · filed 2014-06-10 | $2.07M 10-K · filed 2014-06-10 | ||||||||||
| 2011-09-30 | $182.32K 10-Q · filed 2012-11-14 | $241.16K derived: sum of 2 quarters · filed 2012-11-14 | $294.25K 10-Q · filed 2012-11-14 | |||||||||||
| 2011-06-30 | $58.84K 10-Q · filed 2012-08-14 | $111.92K 10-Q · filed 2012-08-14 | ||||||||||||
| 2011-03-31 | $53.08K 10-Q · filed 2012-05-15 | |||||||||||||
| 2010-12-31 | $161.00K 10-KT · filed 2013-05-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |